Literature DB >> 34356595

On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update.

Jordi Camps1, Helena Castañé1, Elisabet Rodríguez-Tomàs1,2, Gerard Baiges-Gaya1, Anna Hernández-Aguilera1, Meritxell Arenas1,2, Simona Iftimie3, Jorge Joven1.   

Abstract

Infectious and many non-infectious diseases share common molecular mechanisms. Among them, oxidative stress and the subsequent inflammatory reaction are of particular note. Metabolic disorders induced by external agents, be they bacterial or viral pathogens, excessive calorie intake, poor-quality nutrients, or environmental factors produce an imbalance between the production of free radicals and endogenous antioxidant systems; the consequence being the oxidation of lipids, proteins, and nucleic acids. Oxidation and inflammation are closely related, and whether oxidative stress and inflammation represent the causes or consequences of cellular pathology, both produce metabolic alterations that influence the pathogenesis of the disease. In this review, we highlight two key molecules in the regulation of these processes: Paraoxonase-1 (PON1) and chemokine (C-C motif) ligand 2 (CCL2). PON1 is an enzyme bound to high-density lipoproteins. It breaks down lipid peroxides in lipoproteins and cells, participates in the protection conferred by HDL against different infectious agents, and is considered part of the innate immune system. With PON1 deficiency, CCL2 production increases, inducing migration and infiltration of immune cells in target tissues and disturbing normal metabolic function. This disruption involves pathways controlling cellular homeostasis as well as metabolically-driven chronic inflammatory states. Hence, an understanding of these relationships would help improve treatments and, as well, identify new therapeutic targets.

Entities:  

Keywords:  cancer; cardiovascular disease; chemokine (C-C motif) ligand 2; fatty liver; infection; inflammation; metabolism; obesity; paraoxonase-1

Year:  2021        PMID: 34356595     DOI: 10.3390/biom11070971

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  6 in total

1.  Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia.

Authors:  Elisabet Rodríguez-Tomàs; Johana C Acosta; Laura Torres-Royo; Gabriel De Febrer; Gerard Baiges-Gaya; Helena Castañé; Andrea Jiménez; Carlos Vasco; Pablo Araguas; Junior Gómez; Bárbara Malave; Miguel Árquez; David Calderón; Berta Piqué; Manel Algara; Ángel Montero; Josep M Simó; Xavier Gabaldó-Barrios; Sebastià Sabater; Jordi Camps; Jorge Joven; Meritxell Arenas
Journal:  Antioxidants (Basel)       Date:  2022-06-16

Review 2.  The Relationship between Cancer and Paraoxonase 1.

Authors:  Irma Martha Medina-Díaz; Néstor Ponce-Ruíz; Aurora Elizabeth Rojas-García; José Francisco Zambrano-Zargoza; Yael Y Bernal-Hernández; Cyndia Azucena González-Arias; Briscia S Barrón-Vivanco; José Francisco Herrera-Moreno
Journal:  Antioxidants (Basel)       Date:  2022-03-31

3.  Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients.

Authors:  Helena Castañé; Simona Iftimie; Gerard Baiges-Gaya; Elisabet Rodríguez-Tomàs; Andrea Jiménez-Franco; Ana Felisa López-Azcona; Pedro Garrido; Antoni Castro; Jordi Camps; Jorge Joven
Journal:  Metabolism       Date:  2022-04-02       Impact factor: 13.934

4.  Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia.

Authors:  Bíborka Nádró; Hajnalka Lőrincz; Lilla Juhász; Anita Szentpéteri; Ferenc Sztanek; Éva Varga; Dénes Páll; György Paragh; Mariann Harangi
Journal:  Biomedicines       Date:  2022-03-25

5.  Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19.

Authors:  Xavier Gabaldó; Màrius Juanpere; Helena Castañé; Elisabet Rodríguez-Tomàs; Ana Felisa López-Azcona; Gerard Baiges-Gaya; Lourdes Castro; Enrique Valverde-Díaz; Aida Muñoz-Blázquez; Laura Giménez-Cuenca; Laura Felipo-Balada; Frederic Ballester; Isabel Pujol; Josep M Simó; Antoni Castro; Simona Iftimie; Jordi Camps; Jorge Joven
Journal:  Biomolecules       Date:  2022-06-23

6.  Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients.

Authors:  Imre Juhász; Szilvia Ujfalusi; Ildikó Seres; Hajnalka Lőrincz; Viktória Evelin Varga; György Paragh; Sándor Somodi; Mariann Harangi; György Paragh
Journal:  Biomolecules       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.